Skip to main content
. 2023;24(12):4059–4069. doi: 10.31557/APJCP.2023.24.12.4059

Table 6.

Hazard Analysis (p<0.05, significant)

Parameter Group1/Group 2 Frequency P value Hazard Ratio 95% C.I.
(Group 1/ Group 2) Lower Limit Upper Limit
Age group 10-39/40-59 63/106 0.396 0.42 0.056 3.133
10-39/60-79 63/25 0.316 0.361 0.049 2.652
10-39/ 80 and above 63/2 0.055 1.834 0.245 13.746
Gender Male/ Female 127/69 0.518 1.185 0.707 1.986
Splenomegaly Moderate/Mild 36/95 0.001 0.227 0.124 0.414
Massive/Mild 38/95 0.01 0.465 0.26 0.83
Stage Accelerated/Chronic 44/117 0.001 1.09 0.051 0.16
Blast/ Chronic 35/117 0.001 2.34 0.132 0.441
Smoking duration 11-20yrs/1-10yrs 32/24 0.079 0.313 0.086 1.142
21-30yrs/1-10yrs 35/24 0.01 0.173 0.046 0.655
31-40yrs/1-10yrs Apr-24 0.13 0.385 0.112 1.325
Smoking frequency 6-10times/1-5times 35/53 0.055 0.136 0.018 1.044
16-20times/1-5times Jan-53 0.051 0.128 0.016 1.006
Smoking Habit Yes/No 95/101 0.0079 1.54 0.951 2.494
Alcohol intake Yes/No 93/103 0.023 1.751 1.079 2.84
Alcohol duration 11-20yrs/1-10yrs 41/30 0.008 1.32 1.167 2.845
21-30yrs/1-10yrs 23/30 0.019 1.418 1.167 2.845
Giddiness Yes/No 50/145 0.879 1.043 0.558 1.648
Lab diagnosis B3A2/B2A2 132/63 0.588 0.871 0.529 1.435
Resistance NR/R/single allele R 107/39 0.081 1.26 0.972 1.633
DDIT3 Regulation Up regulation/down regulation 104/92 0.027 1.361 0.843 2.198
MGMT regulation Up regulation/ down regulation 107/89 0.001 2.291 1.405 3.736